Patient Services Inc to pay $3million as illegal conduit for drug makers

“Pharmaceutical companies cannot use foundations to funnel drug co-payments disguised as routine charitable donations, all to prop up excessive drug prices,” the US Attorney for the District of Massachusetts said. PSI coordinated with pharmaceutical manufacturers Insys, Aegerion and Alexion on kickbacks to Medicare patients taking their drugs.